Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Olson Scott

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/6/2020

3. Issuer Name and Ticker or Trading Symbol

BOSTON SCIENTIFIC CORP [BSX]

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
SVP & Pres, Rhythm Management /

(Street)

MARLBOROUGH, MA 01752-1234

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	10578.0000	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock Units	⁽¹⁾	2/15/2023 ⁽¹⁾	Common Stock	3876.0000 ⁽²⁾	⁽³⁾	D
Deferred Stock Units	⁽⁴⁾	2/18/2024 ⁽⁴⁾	Common Stock	4150.0000	⁽³⁾	D
Deferred Stock Units	⁽⁵⁾	2/21/2023 ⁽⁵⁾	Common Stock	3271.0000 ⁽⁶⁾	⁽³⁾	D
Deferred Stock Units	⁽⁷⁾	2/28/2022 ⁽⁷⁾	Common Stock	2852.0000 ⁽⁸⁾	⁽³⁾	D
Deferred Stock Units	⁽⁹⁾	7/1/2024 ⁽⁹⁾	Common Stock	7086.0000	⁽³⁾	D
Deferred Stock Units	⁽¹⁰⁾	12/1/2020 ⁽¹⁰⁾	Common Stock	1485.0000 ⁽¹¹⁾	⁽³⁾	D
Stock Option (Right to Buy)	⁽¹²⁾	2/24/2024	Common Stock	5625.0000	$13.0800	D
Stock Option (Right to Buy)	⁽¹³⁾	12/1/2025	Common Stock	14851.0000	$18.5200	D
Stock Option (Right to Buy)	⁽¹⁴⁾	2/28/2027	Common Stock	18939.0000	$24.5500	D
Stock Option (Right to Buy)	⁽¹⁵⁾	2/15/2028	Common Stock	15756.0000	$27.0900	D
Stock Option (Right to Buy)	⁽¹⁶⁾	7/1/2030	Common Stock	29239.0000	$35.2800	D
Stock Option (Right to Buy)	⁽¹⁷⁾	2/21/2029	Common Stock	15060.0000	$40.1200	D
Stock Option (Right to Buy)	⁽¹⁸⁾	2/18/2030	Common Stock	16843.0000	$42.1600	D

Explanation of Responses:
(1)	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
(2)	This amount represents the unvested portion of DSUs awarded on February 15, 2018, which will continue to vest in three remaining installments on the anniversary of the date of grant.
(3)	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
(4)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
(5)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
(6)	This amount represents the unvested portion of DSUs awarded on February 21, 2019, which will continue to vest in three remaining installments on the anniversary of the date of grant.
(7)	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
(8)	This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in two remaining installments on the anniversary of the date of grant.
(9)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant.
(10)	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.
(11)	This amount represents the unvested portion of DSUs awarded on December 1, 2015, which will continue to vest in one remaining installment on the anniversary of the date of grant.
(12)	Grant to the reporting person of an option to purchase 22,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
(13)	Grant to the reporting person of an option to purchase 22,467 shares of common stock vesting in four equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.
(14)	Grant to the reporting person of an option to purchase 25,252 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
(15)	Grant to the reporting person of an option to purchase 21,008 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
(16)	Grant to the reporting person of an option to purchase 29,239 shares of common stock vesting in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant.
(17)	Grant to the reporting person of an option to purchase 15,060 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
(18)	Grant to the reporting person of an option to purchase 16,843 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

Remarks:
olsonpoa.txt

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Olson Scott 300 BOSTON SCIENTIFIC WAY MARLBOROUGH, MA 01752-1234			SVP & Pres, Rhythm Management